Skip to content

NYSE · CIK 0001933567

NRXS Neuraxis, INC

Insider trading from SEC Form 4. Last filing 5 d ago. Close $6.93 on Oct 9, 2026, +200% from the 52-week low and -21% from the high.

Last 90 days

Net insider value
+$12k
more bought than sold
Buys
3
$12k by 3 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company

Price and insider trades, last year

NRXSOct 9, 2026 · close 6.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Neuraxis, INC, scored.

ScoreInsiderValueHoldingsPrice contextFiled
35WeakBrian Allen Carrico
Chief Executive Officer
buy
$1,297
268 shares
+0%-
25WeakThomas Joeseph Carrico
CRO, CCO, CPO
buy
$1,588
328 shares
+0%-
43ModerateTimothy Robert Henrichs
Chief Financial Officer
buy
$9,375
1,937 shares
+26%-
33WeakBrian Allen Carrico
Chief Executive Officer
buy
$16k
8,060 shares
+2%+349% from low-6% from high
18WeakThomas Joeseph Carrico
CRO, CCO, CPO
buy
$1,307
667 shares
+0%+349% from low-6% from high
26WeakBrian Hannasch
owner
buy
$383k
80,000 shares
+7%+191% from low-10% from high
48ModerateGil Aharon
director
buy
$1.0M
286,138 shares
-+118% from low-14% from high
48ModerateBrian Hannasch
owner
buy
$800k
355,556 shares
+46%+49% from low-40% from high
42ModerateMasimo Corp
owner
sell
$1.8M
821,327 shares
-155%+49% from low-40% from high
20WeakBrian Hannasch
owner
buy
$31k
18,065 shares
+2%+12% from low-45% from high

Transactions

The last 40 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 8, 2026Thomas Joeseph Carrico
CRO, CCO, CPO
POpen-market purchase
Common Stock
+328$4.84$1,588199,6735 d ago
Oct 8, 2026Timothy Robert Henrichs
Chief Financial Officer
POpen-market purchase
Common Stock
+1,937$4.84$9,3759,5305 d ago
Oct 8, 2026Brian Allen Carrico
Chief Executive Officer
POpen-market purchase
Common Stock
+268$4.84$1,297227,6045 d ago
Apr 28, 2026Gil Aharon
director
AGrant or award
Common Stock
+12,304--33,902Apr 30, 2026
Apr 28, 2026Gil Aharon
director
AGrant or award
Common Stockindirect: By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.
+221,917--508,055Apr 30, 2026
Apr 1, 2026Brian Allen Carrico
Chief Executive Officer
POpen-market purchase
Common Stock
+8,060$1.96$16k348,178Apr 3, 2026
Apr 1, 2026Thomas Joeseph Carrico
CRO, CCO, CPO
POpen-market purchase
Common Stock
+667$1.96$1,307331,903Apr 3, 2026
Jan 22, 2026Adrian Miranda
CMO, SVP Science & Tech
AGrant or award
RSUderivative
+47,569$4.63$220k47,569Mar 2, 2026
Jan 22, 2026Bradley Mitchell Watkins
director
AGrant or award
Common Stock
+21,598$4.63$100k46,335Feb 26, 2026
Jan 22, 2026Jane Elizabeth Keyser
director
AGrant or award
Common Stock
+21,598$4.63$100k46,335Feb 26, 2026
Jan 22, 2026Timothy Robert Henrichs
Chief Financial Officer
AGrant or award
RSUderivative
+75,231$4.63$348k75,231Feb 26, 2026
Jan 22, 2026Brian Allen Carrico
Chief Executive Officer
AGrant or award
RSUderivative
+94,173$4.63$436k94,173Feb 26, 2026
Jan 22, 2026Thomas Joeseph Carrico
CRO, CCO, CPO
AGrant or award
RSUderivative
+47,569$4.63$220k47,569Feb 26, 2026
Feb 11, 2026Brian Hannasch
owner
POpen-market purchase
Common Stock
+40,000$4.65$186k1,171,522Feb 13, 2026
Feb 12, 2026Brian Hannasch
owner
POpen-market purchase
Common Stock
+40,000$4.92$197k1,211,522Feb 13, 2026
Jan 22, 2026Kristin A Ferge
director
AGrant or award
Common Stock
+21,598$4.63$100k35,938Jan 30, 2026
Jan 22, 2026Gil Aharon
director
AGrant or award
Common Shares
+21,598$4.63$100k307,736Jan 30, 2026
Dec 23, 2025Gil Aharon
director
POpen-market purchase
Common Sharesindirect: By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.
+286,138$3.52$1.0M286,138Dec 29, 2025
Mar 4, 2025Adrian Miranda
CMO, SVP Science & Tech
AGrant or award
RSUderivative
+10,000$2.18$22k10,000Sep 10, 2025
Mar 4, 2025Thomas Joeseph Carrico
CRO, CCO, CPO
AGrant or award
RSUderivative
+10,000$2.18$22k10,000Sep 10, 2025
Mar 4, 2025Brian Allen Carrico
Chief Executive Officer
AGrant or award
RSUderivative
+10,000$2.18$22k10,000Sep 10, 2025
Mar 18, 2025Timothy Robert Henrichs
Chief Financial Officer
AGrant or award
RSUderivative
+8,037$2.43$20k8,037Sep 10, 2025
Jan 17, 2025Kristin A Ferge
director
AGrant or award
Common Stock
+13,157$2.85$37k14,340Sep 10, 2025
Jan 17, 2025Jane Elizabeth Keyser
director
AGrant or award
Common Stock
+13,157$2.85$37k24,737Sep 10, 2025
Jan 17, 2025Bradley Mitchell Watkins
director
AGrant or award
Common Stock
+13,157$2.85$37k24,737Sep 10, 2025
Mar 18, 2025Timothy Robert Henrichs
Chief Financial Officer
AGrant or award
RSUderivative
+100,000$2.43$243k100,000Sep 10, 2025
Mar 4, 2025Brian Allen Carrico
Chief Executive Officer
AGrant or award
RSUderivative
+90,640$2.18$198k90,640Sep 10, 2025
Mar 4, 2025Thomas Joeseph Carrico
CRO, CCO, CPO
AGrant or award
RSUderivative
+27,435$2.18$60k27,435Sep 10, 2025
Mar 4, 2025Adrian Miranda
CMO, SVP Science & Tech
AGrant or award
RSUderivative
+30,000$2.18$65k30,000Sep 10, 2025
Jan 3, 2025Brian Allen Carrico
Chief Executive Officer
AGrant or award
RSUderivative
+70,019$2.42$169k70,019Sep 10, 2025
Jan 3, 2025Thomas Joeseph Carrico
CRO, CCO, CPO
AGrant or award
RSUderivative
+35,000$2.42$85k35,000Sep 10, 2025
Jan 3, 2025Adrian Miranda
CMO, SVP Science & Tech
AGrant or award
RSUderivative
+35,000$2.42$85k35,000Sep 10, 2025
Mar 4, 2025Timothy Robert Henrichs
Chief Financial Officer
AGrant or award
RSUderivative
+66,000$2.18$144k66,000Sep 10, 2025
Jan 3, 2025Timothy Robert Henrichs
Chief Financial Officer
AGrant or award
RSUderivative
+67,980$2.42$165k67,980Sep 10, 2025
Jul 1, 2025Masimo Corp
owner
SOpen-market sale
Common Stock
-531,548$2.25$1.2M0Jul 3, 2025
Jul 1, 2025Brian Hannasch
owner
POpen-market purchase
Common Stock
+355,556$2.25$800k1,131,522Jul 3, 2025
Jul 1, 2025Masimo Corp
owner
CConversion
Common Stock
+289,779$0.00$29289,779Jul 3, 2025
Jul 1, 2025Masimo Corp
owner
SOpen-market sale
Common Stock
-289,779$2.25$652k0Jul 3, 2025
Jul 1, 2025Masimo Corp
owner
MOption exercise
Pre-Funded Warrant, Common Stock (Right to Buy)derivative
-289,779$0.00$00Jul 3, 2025
Apr 21, 2025Brian Hannasch
owner
POpen-market purchase
Common Stock
+18,065$1.73$31k775,966Apr 23, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

NRXS insider trading: Neuraxis, INC | InsiderTell